4 Results for "

PR104

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PR104" in MCE Product Catalog:

Art. -Nr.: HY-16405
CAS. Nr.: 851627-62-8
Forschungsgebiete:  

Cancer

PR-104 is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104, as a nitrogen mustard pre-proagent, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A .
loading...
    loading...
Art. -Nr.: HY-14572
CAS. Nr.: 680199-06-8
Synonyms: SN 27858
Forschungsgebiete:  

Cancer

PR-104A (SN 27858) is the alcohol metabolite of phosphate proagent PR-104. PR-104A is a hypoxia-selective DNA cross-linking agent/DNA-damaging agent and cytotoxin. Antitumor Activity . PR-104A is metabolized under hypoxia by the 1-electron NADPH:cytochrome P450 oxidoreductase. PR-104A can be used for the research of relapsed/refractory T-lineage acute lymphoblastic leukemia (T-ALL) .
loading...
    loading...
Art. -Nr.: HY-16406
CAS. Nr.: 851627-80-0
Forschungsgebiete:  

Cancer

PR-104 (sodium) is a selective hypoxia-activated DNA cross-linking agent and can be used for the research of multiple tumor xenograft models. PR-104 (sodium), as a nitrogen mustard pre-proagent, is converted efficiently to the more lipophilic dinitrobenzamide mustards alcohol PR-104A .
loading...
    loading...
Art. -Nr.: HY-116170
CAS. Nr.: 1548116-54-6
Target:  

17β-HSD

Forschungsgebiete:  

Cancer

SN34037 is a specific inhibitor of Aldo-keto reductase 1C3 (AKR1C3, EC 1.1.1.188) with the ability to inhibit the cytotoxic activity of PR-104A. SN34037-sensitive coumberone reduction provides a rapid and specific assay for AKR1C3 activity. SN34037 inhibits the aerobic cytotoxicity of PR-104A in TF1 erythroleukemia cells with high AKR1C3 expression, but not in Nalm6 pre-B acute lymphoblastic leukemia cells with low AKR1C3 expression .
loading...
    loading...